MICHAEL JOHN TOMSICEK Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL JOHN TOMSICEK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL JOHN TOMSICEK. MICHAEL JOHN TOMSICEK is Vice President, CFO in ABIOMED INC ($ABMD) and SVP & Chief Financial Officer in CUBIST PHARMACEUTICALS INC ($CBST) and Director in Milestone Pharmaceuticals Inc. ($MIST) and Chief Financial Officer in CRISPR Therapeutics AG ($CRSP).
Latest Insider Trading Transactions of MICHAEL JOHN TOMSICEK
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABMD, CRSP, CBST, MIST
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 133.88 | 25,360 | 3,395,197 | 25,360 | |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Payment of Exercise | F | 124.15 | 1,352 | 167,851 | 1,891 | 3.2 K to 1.9 K (-41.69 %) |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Buy | M | 0.00 | 2,833 | 0 | 3,243 | 410 to 3.2 K (+690.98 %) |
| Oct 06 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 86.75 | 11,666 | 1,012,026 | 11,666 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | M | 17.75 | 12,000 | 213,000 | 156,000 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 93.18 | 2,800 | 260,904 | 410 | 3.2 K to 410 (-87.23 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 92.23 | 6,400 | 590,272 | 3,210 | 9.6 K to 3.2 K (-66.60 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 91.39 | 2,800 | 255,892 | 9,610 | 12.4 K to 9.6 K (-22.56 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Buy | M | 17.75 | 12,000 | 213,000 | 12,410 | 410 to 12.4 K (+2,926.83 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | M | 17.75 | 12,000 | 213,000 | 156,000 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 93.18 | 2,800 | 260,904 | 410 | 3.2 K to 410 (-87.23 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 92.23 | 6,400 | 590,272 | 3,210 | 9.6 K to 3.2 K (-66.60 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 91.39 | 2,800 | 255,892 | 9,610 | 12.4 K to 9.6 K (-22.56 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Buy | M | 17.75 | 12,000 | 213,000 | 12,410 | 410 to 12.4 K (+2,926.83 %) |
| Aug 05 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | M | 17.75 | 12,000 | 213,000 | 168,000 | |
| Aug 05 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 87.33 | 5,448 | 475,790 | 410 | 5.9 K to 410 (-93.00 %) |
| Aug 05 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 86.25 | 6,552 | 565,128 | 5,858 | 12.4 K to 5.9 K (-52.80 %) |
| Aug 05 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Buy | M | 17.75 | 12,000 | 213,000 | 12,410 | 410 to 12.4 K (+2,926.83 %) |
| Jun 08 2020 | MIST | Milestone Pharmace ... | TOMSICEK MICHAEL JOHN | Director | Option Exercise | A | 3.74 | 15,000 | 56,100 | 15,000 | |
| Mar 12 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 0.00 | 8,500 | 0 | 8,500 | |
| Mar 12 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 44.67 | 35,000 | 1,563,450 | 35,000 | |
| Dec 05 2019 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Mar 07 2019 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 40.87 | 75,000 | 3,065,250 | 75,000 | |
| Jun 15 2018 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 59.31 | 20,760 | 1,231,276 | 20,760 | |
| Jun 15 2018 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 59.31 | 20,760 | 1,231,276 | 20,760 | |
| Mar 09 2018 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 51.49 | 25,000 | 1,287,250 | 25,000 | |
| Nov 14 2017 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 17.75 | 180,000 | 3,195,000 | 180,000 | |
| Jul 18 2017 | ABMD | ABIOMED INC | TOMSICEK MICHAEL JOHN | Vice President, CFO | Payment of Exercise | F | 145.07 | 3,925 | 569,400 | 27,081 | 31 K to 27.1 K (-12.66 %) |
| May 26 2017 | ABMD | ABIOMED INC | TOMSICEK MICHAEL JOHN | Vice President, CFO | Payment of Exercise | F | 134.74 | 1,567 | 211,138 | 34,931 | 36.5 K to 34.9 K (-4.29 %) |
| May 26 2016 | ABMD | ABIOMED INC | TOMSICEK MICHAEL JOHN | Vice President, CFO | Option Exercise | A | 99.62 | 5,000 | 498,100 | 5,000 | |
| May 26 2016 | ABMD | ABIOMED INC | TOMSICEK MICHAEL JOHN | Vice President, CFO | Option Exercise | A | 67.55 | 25,000 | 1,688,750 | 25,000 | |
| May 26 2016 | ABMD | ABIOMED INC | TOMSICEK MICHAEL JOHN | Vice President, CFO | Grant | A | 0.00 | 1,800 | 0 | 26,800 | 25 K to 26.8 K (+7.20 %) |
| Jul 20 2015 | ABMD | ABIOMED INC | TOMSICEK MICHAEL JOHN | Vice President, CFO | Option Exercise | A | 67.55 | 25,000 | 1,688,750 | 25,000 | |
| Jul 20 2015 | ABMD | ABIOMED INC | TOMSICEK MICHAEL JOHN | Vice President, CFO | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 0.00 | 4,029 | 0 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 0.00 | 4,365 | 0 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 73.55 | 31,559 | 2,321,164 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 0.00 | 4,085 | 0 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 45.90 | 17,233 | 790,995 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 0.00 | 3,004 | 0 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 0.00 | 2,253 | 0 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 41.60 | 18,404 | 765,606 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 0.00 | 2,500 | 0 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 43.81 | 15,000 | 657,150 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 0.00 | 1,667 | 0 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 42.09 | 10,000 | 420,900 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 34.80 | 5,875 | 204,421 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | D | 0.00 | 1,500 | 0 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Sell | J | 102.00 | 1,199 | 122,298 | 0 | 1.2 K to 0 (-100.00 %) |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Sell | J | 102.00 | 14,765 | 1,506,030 | 0 | 14.8 K to 0 (-100.00 %) |
| Dec 31 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | M | 23.50 | 20,000 | 470,000 | 0 | |
| Dec 31 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Payment of Exercise | F | 100.71 | 11,367 | 1,144,771 | 14,765 | 26.1 K to 14.8 K (-43.50 %) |
| Dec 31 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | M | 23.50 | 20,000 | 470,000 | 26,132 | 6.1 K to 26.1 K (+326.16 %) |
| Oct 02 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | J | 66.34 | 63 | 4,179 | 1,199 | 1.1 K to 1.2 K (+5.55 %) |
| Aug 18 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | M | 0.00 | 1,250 | 0 | 2,500 | |
| Aug 18 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Sell | S | 63.68 | 409 | 26,043 | 6,132 | 6.5 K to 6.1 K (-6.25 %) |
| Aug 18 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | M | 0.00 | 1,250 | 0 | 6,541 | 5.3 K to 6.5 K (+23.63 %) |
| Jul 02 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | J | 69.82 | 82 | 5,725 | 1,136 | 1.1 K to 1.1 K (+7.78 %) |
| May 14 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | M | 0.00 | 1,500 | 0 | 3,000 | |
| May 14 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Sell | S | 69.00 | 499 | 34,431 | 5,291 | 5.8 K to 5.3 K (-8.62 %) |
| May 14 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | M | 0.00 | 1,500 | 0 | 5,790 | 4.3 K to 5.8 K (+34.97 %) |
| Apr 16 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | M | 0.00 | 1,361 | 0 | 4,085 | |
| Apr 16 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Sell | S | 64.00 | 441 | 28,224 | 4,290 | 4.7 K to 4.3 K (-9.32 %) |
| Apr 16 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | M | 0.00 | 1,361 | 0 | 4,731 | 3.4 K to 4.7 K (+40.39 %) |
| Apr 02 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | J | 73.15 | 77 | 5,633 | 1,054 | 977 to 1.1 K (+7.88 %) |
| Feb 19 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | M | 0.00 | 833 | 0 | 2,500 | |
| Feb 19 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | M | 0.00 | 751 | 0 | 2,253 | |
| Feb 19 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | A | 0.00 | 4,029 | 0 | 4,029 | |
| Feb 19 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | A | 0.00 | 4,365 | 0 | 4,365 | |
| Feb 19 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | A | 73.55 | 31,559 | 2,321,164 | 31,559 | |
| Feb 19 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Sell | S | 75.00 | 555 | 41,625 | 3,370 | 3.9 K to 3.4 K (-14.14 %) |
| Feb 19 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | M | 0.00 | 833 | 0 | 3,925 | 3.1 K to 3.9 K (+26.94 %) |
| Feb 19 2014 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | M | 0.00 | 751 | 0 | 3,092 | 2.3 K to 3.1 K (+32.08 %) |
| Oct 02 2013 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | J | 63.55 | 74 | 4,703 | 977 | 903 to 977 (+8.19 %) |
| Sep 05 2013 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Sell | S | 64.08 | 400 | 25,632 | 2,341 | 2.7 K to 2.3 K (-14.59 %) |
| Aug 16 2013 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| Aug 16 2013 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | M | 0.00 | 1,250 | 0 | 2,741 | 1.5 K to 2.7 K (+83.84 %) |
| Jul 02 2013 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | J | 48.29 | 114 | 5,505 | 903 | 789 to 903 (+14.45 %) |
| Jul 02 2013 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | J | 36.69 | 288 | 10,566 | 1,491 | 1.2 K to 1.5 K (+23.94 %) |
| May 15 2013 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | M | 0.00 | 1,500 | 0 | 4,500 | |
| May 15 2013 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Sell | S | 49.18 | 488 | 23,999 | 1,203 | 1.7 K to 1.2 K (-28.86 %) |
| May 15 2013 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | M | 0.00 | 1,500 | 0 | 1,691 | 191 to 1.7 K (+785.34 %) |
| Apr 16 2013 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | A | 0.00 | 5,446 | 0 | 5,446 | |
| Apr 16 2013 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Option Exercise | A | 45.90 | 17,233 | 790,995 | 17,233 | |
| Apr 02 2013 | CBST | CUBIST PHARMACEUTI ... | TOMSICEK MICHAEL JOHN | SVP & Chief Financi ... | Buy | J | 46.82 | 108 | 5,057 | 789 | 681 to 789 (+15.86 %) |
Page: 1